vTv Therapeutics Inc. announced entry into agreements that include a $10 million investment by CinPax, LLC, a subsidiary of CinRx Pharma, LLC. Dr. Jon Isaacsohn, Chief Executive Officer of CinRx, who has been involved in the clinical development of countless therapeutics, is expected to join the vTv Board of Directors.